MA55568A - Compositions pharmaceutiques orodispersibles d'apixaban - Google Patents

Compositions pharmaceutiques orodispersibles d'apixaban

Info

Publication number
MA55568A
MA55568A MA055568A MA55568A MA55568A MA 55568 A MA55568 A MA 55568A MA 055568 A MA055568 A MA 055568A MA 55568 A MA55568 A MA 55568A MA 55568 A MA55568 A MA 55568A
Authority
MA
Morocco
Prior art keywords
apixaban
pharmaceutical compositions
orodispersible pharmaceutical
orodispersible
compositions
Prior art date
Application number
MA055568A
Other languages
English (en)
Inventor
Shivang Prajapati
Ramesh Shingala
Balvir Singh
Original Assignee
Unison Pharmaceuticals Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unison Pharmaceuticals Pvt Ltd filed Critical Unison Pharmaceuticals Pvt Ltd
Publication of MA55568A publication Critical patent/MA55568A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA055568A 2019-11-13 2020-10-31 Compositions pharmaceutiques orodispersibles d'apixaban MA55568A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201921046107 2019-11-13

Publications (1)

Publication Number Publication Date
MA55568A true MA55568A (fr) 2022-02-09

Family

ID=75911423

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055568A MA55568A (fr) 2019-11-13 2020-10-31 Compositions pharmaceutiques orodispersibles d'apixaban

Country Status (11)

Country Link
US (1) US20220211689A1 (fr)
EP (1) EP3946277A4 (fr)
JP (1) JP2023502209A (fr)
KR (1) KR20220101103A (fr)
AU (2) AU2020384737A1 (fr)
BR (1) BR112022008551A2 (fr)
CA (1) CA3156572A1 (fr)
MA (1) MA55568A (fr)
MX (1) MX2022005503A (fr)
WO (1) WO2021095048A1 (fr)
ZA (1) ZA202204907B (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102908324A (zh) * 2012-10-31 2013-02-06 南京正科制药有限公司 一种阿哌沙班片
CN104173313B (zh) * 2014-08-25 2017-05-17 杭州朱养心药业有限公司 利伐沙班片剂药物组合物
IN201641006652A (fr) * 2016-02-25 2017-11-24
CN107661301A (zh) * 2016-07-29 2018-02-06 天津市汉康医药生物技术有限公司 一种阿哌沙班药物组合物及其制备方法
TWI812602B (zh) * 2016-12-01 2023-08-21 日商第一三共股份有限公司 含二胺衍生物之口腔崩散錠及其製造方法

Also Published As

Publication number Publication date
ZA202204907B (en) 2024-03-27
EP3946277A4 (fr) 2022-06-15
CA3156572A1 (fr) 2021-05-20
AU2023203908A1 (en) 2023-07-06
US20220211689A1 (en) 2022-07-07
WO2021095048A1 (fr) 2021-05-20
BR112022008551A2 (pt) 2022-08-09
MX2022005503A (es) 2022-06-02
EP3946277A1 (fr) 2022-02-09
JP2023502209A (ja) 2023-01-23
KR20220101103A (ko) 2022-07-19
AU2020384737A1 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
MA51796A (fr) Procédés et compositions pour l'administration de protéines thérapeutiques
MA55206A (fr) Polyribonucléotides circulaires et compositions pharmaceutiques associées
EA201992116A1 (ru) Фармацевтические составы флороглюцинола и триметилфлороглюцинола
MD3442972T2 (ro) Inhibitori ai bromodomeniului
CY1119007T1 (el) Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης
MA51747A (fr) Formulation d'anticorps pharmaceutique à ph faible
MA45688A (fr) Compositions et procédés de potentialisation d'agents antimicrobiens
MA52118A (fr) Nouveaux composés et compositions pharmaceutiques de ceux-ci destinés au traitement de la fibrose
IL288375A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
MA50189A (fr) Formulations pharmaceutiques d'oligomère cyclique et d'abiratérone et procédés de formation et d'administration de celles-ci
EA202191114A1 (ru) Производные пиридинилсульфонамида, фармацевтические композиции и их применение
WO2018183631A8 (fr) Nouvelles formulations pharmaceutiques contenant de l'indirubine et des dérivés de celui-ci et procédés de fabrication et d'utilisation de celles-ci
ES2850277R1 (es) Composiciones de administración farmacéutica y usos de las mismas
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201911868D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA50670A (fr) Nouvelles formulations permettant de stabiliser des compositions d'anticorps à faible dose
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
IL286677A (en) New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders
IL286688A (en) New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders
MA55015A (fr) Formulations pharmaceutiques
MA55033A (fr) Formulation d'anticorps thérapeutique
MA53333A (fr) Formulations pharmaceutiques d'anticorps masqués
EA201991490A1 (ru) Ароматические амиды карбоновых кислот в качестве антагонистов рецепторов брадикинина в1
CY1116274T1 (el) Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας
MA53099A (fr) Formes d'ivosidénib et compositions pharmaceutiques